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Edited by Vladimir SkulachevAbstract Mitochondrial uncoupling protein 2 (UCP2) is abun-
dant in developing monocyte/macrophage cells and may aﬀect
hematopoiesis by reducing formation of reactive oxygen species.
The aims of this study were to further characterize the involve-
ment of UCP2 in hematopoiesis. In situ hybridization in mouse
embryos identiﬁed UCP2-positive cells in liver and inside primi-
tive blood vessels from 10.5 days of prenatal development. High
UCP2 transcript levels were detected in reticulocytes and other
maturating erythroid cells in peripheral blood of mice exposed
to hypoxia, and in umbilical cord blood of human neonates and
peripheral blood of adults. Our results suggest involvement of
UCP2 in erythropoiesis.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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development1. Introduction
Factors that aﬀect hematopoietic cells replication, growth
and diﬀerentiation are only partially understood. New cell-
type or cell-process speciﬁc markers are required. Our previous
studies demonstrated high expression of mitochondrial uncou-
pling protein 2 (UCP2) in monocyte/macrophage cells develop-
ing prenatally in rodent [1] and human [2] liver. Thus, in
contrast to postnatal life when UCP2 is expressed mainly in
spleen, lung, intestine, white adipose tissue, and immune cellsAbbreviations: EF-1a, elongation factor-1a; HBB, human hemoglobin
b; HBB-b1, adult major chain of mouse hemoglobin b; HPRT1, hy-
poxanthine-guanine phosphoribosyl-transferase; qRT-PCR, real-time
quantitative PCR; RBC, red blood cells; MNC, mononuclear cells;
ROS, reactive oxygen species; UCP2, uncoupling protein 2
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doi:10.1016/j.febslet.2007.02.012[3], during the intrauterine development, liver represents a ma-
jor site of UCP2 expression. Both in mice and humans, hepatic
UCP2 expression starts to decline rapidly at birth, reﬂecting
the migration of hematopoiesis from the liver to the bone mar-
row during this period of development [1,2]. These data sug-
gest involvement of UCP2 in myeloid cells diﬀerentiation
and function, also in accordance with the presence of UCP2
in Kuppfer cells in adult rodents and with the role of UCP2
in regulation of the production of reactive oxygen species
(ROS) in macrophages [4]. UCP2 may diminish formation of
ROS both in mitochondria [4], and also by the NADPH oxi-
dase complex, via its protonophoric short-circuiting activity
in the inner mitochondrial membrane [5], and through the
reduction of mitochondrial ATP synthesis and cytosolic
NADPH level [6], respectively. In turn, UCP2 activity is in-
duced by ROS [5].
The role of UCP2 in the control of ROS production has
been well demonstrated using UCP2-null mice. Their macro-
phages generated high levels of ROS and these mice were resis-
tant to infection by the intracellular parasite Toxoplasma
gondii [7], supporting the function of UCP2 in the cells of im-
mune system [3]. Liver of UCP2-null mice had elevated mark-
ers of ROS production and exhibited delayed regeneration
after partial hepatectomy, suggesting that UCP2 protects
against ROS-induced injury [8]. The lack of UCP2 led to oxi-
dative stress and accelerated atherosclerotic plaque develop-
ment, suggesting that UCP2 protects against ROS-mediated
atherosclerosis [9].
Previous studies [10,11] demonstrated that formation of
ROS in hematopoietic progenitor cells was induced by cyto-
kines including erythropoietin, and suggested that generation
of ROS induced by hematopoietic cytokines played role in
activation of receptor-mediated signaling and in cell progres-
sion. Therefore, the aims of this study were to further charac-
terize the involvement of UCP2 in hematopoiesis and to learn
whether, in addition to myeloid cells, also other hematopoietic
lineages cells could express UCP2 in vivo. UCP2 expression
was analyzed: (i) during early prenatal development of mice;
(ii) in peripheral blood of mice exposed to hypoxia; and (iii)blished by Elsevier B.V. All rights reserved.
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nates and peripheral blood of adults. Our results document
high levels of UCP2 transcript in maturating red blood cells
(RBC) in both mice and humans, especially in reticulocytes,
and suggest involvement of UCP2 in erythropoiesis.2. Materials and methods
2.1. Animals
Male C57BL/6J mice were housed in a controlled environment
(20 C; 12-h light–dark cycle; light from 7:00 a.m.) with free access
to water and standard chow diet. Embryos and fetuses were obtained
by Caesarean sections between 9.5 and 14.5 days of gestation. Some
mice, at the age of 3 months, were exposed to permanent hypoxia
(FIO2 0.10) using a normobaric chamber equipped with hypoxic gen-
erators (Everest Summit, Hypoxico Inc., NY, USA) for up to two
weeks. At the end of this period, mice exposed to hypoxia as well as
normoxic (FIO2 0.21) controls were killed by cervical dislocation
and truncal blood was used for RNA isolation. All procedures were
performed in accordance with the institutional guidelines for animal
research.2.2. Isolation and fractionation of human blood cells
Samples of umbilical cord blood from mature newborns and periph-
eral blood from adult healthy donors were collected after appropriate
informed consents and used immediately for isolation of blood cells
(lithium heparin added). Peripheral blood mononuclear cells (MNC)
were isolated by centrifugation on density gradient of Ficoll-Paque
PLUS (Amersham Biosciences AB, Uppsala, Sweden) using standard
procedure. Mononuclear layer and plasma were removed, cells were
stored in liquid nitrogen; pellet was fractionated further: (i) in order
to prepare granulocyte fraction, the upper part of the pellet was col-
lected and contaminating RBC were destroyed by hypotonic lysis using
FACS lysing solution (BD, San Jose, CA, USA), (ii) RBC were col-
lected from the bottom layer of the pellet. Purity of the isolated cells
was veriﬁed on FACSCalibur (BD, San Jose, CA, USA) through opti-
cal characteristics of the cells represented by detected forward and side
scatter values. The samples with higher than 95% purity were stored in
liquid nitrogen and used for further analysis. Reticulocytes were iso-
lated from Na-EDTA anti-coagulated whole blood stained with thia-
zol orange [12] (Sigma–Aldrich, St. Louis, USA; 0.2 lg/ml in PBS
containing 2 mM EDTA, pH 7.4) by ﬂow sorting on FACS VantageSE
(BD Biosciences, San Diego, USA) in a two-round sort. In the ﬁrst
round, thiazol orange weakly positive reticulocytes were enriched by
ultra high speed sorting at 80000 cells/s with the threshold set on thia-
zol orange ﬂuorescence. In the second round, reticulocytes were re-
sorted from enriched cell suspension by standard high speed sort
according their weak thiazol orange positivity. Highly positive normo-
blasts and white blood cells were excluded. Erythrocytes were sorted
separately as thiazol orange negative population of RBC. Purity of
sorted cells was veriﬁed by reanalysis on ﬂow cytometer (for reticulo-
cytes >93% in all experiments, for erythrocytes >99.9%). Isolated cell
fractions were stored in liquid nitrogen.2.3. RNA analysis
Total RNA was isolated (TRI Reagent, MRC, Cincinnati, OH,
USA) and levels of diﬀerent transcripts were evaluated using real-time
quantitative PCR (qRT-PCR) using DyNamo Capillary SYBR Green
qPCR kit (Finnzymes, Espoo, Finland) and LightCycler 2.0 instru-
ment (Roche Diagnostics, Mannheim, Germany). Sequences of prim-
ers for human and mouse genes for UCP2, elongation factor-1a
(EF-1a) and b-cyclophilin were already published [13,14]. Primers de-
signed for mouse hypoxanthine-guanine phosphoribosyl-transferase
(HPRT1), human hemoglobin b (HBB) and adult major chain of




respectively. Values for each transcript represent means of at least two
independent measurements. To correct for intersample variation, con-
centrations of the transcript were normalized using EF-1a, as an inter-nal standard; similar results were obtained using b-cyclophilin (and in
the case of mouse samples, also using HPRT1; see also Fig. 2).2.4. In situ detection of UCP2 transcript
In order to localize UCP2 transcript in whole embryos/fetuses sec-
tions, in situ hybridization was performed overnight at 42 C in a solu-
tion containing salmon sperm DNA (40 lg/ml) and antisense UCP2
DIG-labelled RNA probe (0.5 lg/ml), similarly as before [2]. Sections
were counterstained with nuclear red.
2.5. Statistics
Statistical signiﬁcance of diﬀerences between groups was evaluated
using Student’s t-test. The level of signiﬁcance was set at P = 0.05.3. Results
3.1. UCP2 gene transcript in hematopoietic cells during early
prenatal development of mice
Results of our previous study on the prenatal development
in mice [1] indicated recruitment of UCP2 gene just before
10 days of gestation. Beginning from 15 days of gestation, total
RNA could be isolated from several organs and tissues and rel-
atively high levels of UCP2 transcript were detected in liver,
lung, and spleen, while expression of UCP2 in other tissues
was low [1]. In the present study, in order to localize the site
of the expression during early stages of prenatal development,
in situ hybridization analysis of UCP2 was performed in sec-
tions of whole murine embryos/fetuses between 9.5 and 14.5
days of gestation. The sections were stained using antisense
UCP2 DIG-labelled RNA probe (Fig. 1). In accordance with
the previous results (see above) UCP2 transcript could not
be detected in a 9.5-day-old embryo (Fig. 1A). Between 10.5
and 11.5 days of gestation, UCP2 transcript was found in liver
(Fig. 1B) and inside primitive blood vessels (Fig. 1C) but not in
any other tissue (not shown). Cells expressing UCP2 in the li-
ver were very few and this pattern of expression remained sim-
ilar between 10.5 days of gestation (Fig. 1B) and 3 days after
birth [1]. As observed before in our studies in both mice and
humans (see Figs. 4 in Refs. [1,2]), hepatic expression of
UCP2 was localized in non-parenchymal cells and not in hepa-
tocytes. Most of the UCP2-positive cells had sinusoid localiza-
tion and exhibited morphology of monocyte/macrophage cells
(not shown here). However, occasionally, as demonstrated in
liver of a 14.5-day-old fetus (Fig. 1D), UCP2 signal was de-
tected in nucleated cells containing hemoglobin and showing
erythroblast morphology. These results indicate expression of
UCP2 in both myeloid and erythropoietic cells during early
stages of their intrauterine development.3.2. UCP2 expression in peripheral blood in mice during
prolonged hypoxia
In order to better understand the physiological role of UCP2
in erythropoiesis, we examined UCP2 expression in peripheral
blood in adult mice exposed to normobaric hypoxia (see Sec-
tion 2). The expression of UCP2 and of a reticulocyte marker,
HBB-b1 gene [15], was characterized in the blood after 1, 2, 3,
4, 11, and 15 days of hypoxia. Transcripts of three housekeep-
ing/maintenance genes, including b-cyclophilin, EF-1a, and
HPRT1, were also quantiﬁed. When normalized to EF-1a
mRNA, the abundance of the transcripts for both UCP2 and
HBB-b1 transiently increased during the ﬁrst 2 days, declined
to the original level within the following 2 days, and increased
Fig. 1. Detection of UCP2-expressing cells during intrauterine development of mice. UCP2 transcript was detected in sections of whole embryos/
fetuses between 9.5 and 14.5 days of gestation using in situ hybridization. Blue colour corresponds to a positive signal. Slides were counterstained
with nuclear red. Except for panel A, only parts of the sections are shown. (A) Whole embryo at 9.5 days, no UCP2 signal was detected. (B) Liver at
10.5 days, very few UCP2-positive cells were detected. (C) Primitive blood vessel at 11.5 days, many nucleated cells inside the vessels are stained for
UCP2 transcript. (D) Liver at 14.5 days, a selected picture with positive signal in nucleated red blood cells (erythroblasts). Arrows mark hemoglobin.
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Similarly to the expression of UCP2 and HBB-b1, also hemat-
ocrit transiently increased during the beginning of hypoxia and
rose again after 5 days of the exposure. However, after 11 days
of the exposure, levels of the UCP2 and HBB-b1 declined,
while the hematocrit values remained elevated (Fig. 2).
The pattern of UCP2 and HBB-b1 expression was not af-
fected by the gene used for the normalization, since expression
of neither of the housekeeping/maintenance genes measured
was aﬀected by hypoxia. This was documented by a stable level
of expression of b-cyclophilin (Fig. 2) or HPRT1 (not shown)
normalized to EF-1a mRNA.
3.3. UCP2 expression in human blood cells
Levels of UCP2 transcripts were quantiﬁed in cell fractions
separated from umbilical cord blood of human neonates and
from peripheral blood of human adults, respectively (Fig. 3).
Independent of the blood donor, UCP2 expression (normal-
ized to EF-1a mRNA – Fig. 3; or to b-cyclophilin mRNA –
not shown) was relatively low in granulocytes and MNC and
there was no expression in erythrocytes. On the other hand,
surprisingly high expression of UCP2 was found in RBC and
in reticulocytes. The highest UCP2 mRNA level was found
in RBC isolated from the umbilical cord blood, where it was
about 4-fold higher than in reticulocytes. However, Western
blot analysis using hUCP2-605 antibodies [3] could not detect
UCP2 protein in 100000 · g membranes prepared from theRBC isolated from umbilical blood and indicated that UCP2
protein content was relatively low (not shown).
In RBC of adults, UCP2 transcript levels were several fold
lower compared with neonates and they were similar to that
in reticulocytes of the adults. Expression pattern of the reticu-
locyte marker HBB in various blood cells was very similar to
that of UCP2 (not shown).4. Discussion
Principal ﬁnding of this report is the high abundance of
mitochondrial UCP2 transcript in maturing erythroid cells
in vivo. This observation was made in both mice and humans.
Our results are in accordance with the recently published data
of Fujiwara and colleagues who identiﬁed UCP2 as a novel
erythroid-speciﬁc heme-regulated gene while studying wild-
type and heme-deﬁcient erythroblasts in vitro [16]. Our results
show for the ﬁrst time expression of UCP2 in reticulocytes. In
addition, we have found that during intrauterine development
of the mice, UCP2 gene is ﬁrst recruited in hematopoietic cells
before its expression in other cell types and tissues.
The UCP2-positive cells could be detected by in situ hybrid-
ization, around 11 days of gestation at the earliest, in liver and
inside primitive blood vessels, but not in other tissues. At later
stages of the intrauterine development, the liver UCP2 expres-
sion was localized not only in myeloid cells, as we have
Fig. 2. Changes of gene expression and hematocrit in peripheral blood
of mice exposed to normobaric hypoxia. UCP2, HBB-b1 and b-
cyclophilin transcript were quantiﬁed and normalized to EF-1a
mRNA. Hematocrit was estimated in peripheral blood. Day 0,
values in normoxic control mice. Data are means ± S.E. (n = 6–8).
*, signiﬁcantly diﬀerent from normoxic controls.
Fig. 3. Detection of UCP2 expression in human blood cells. UCP2
transcript was quantiﬁed using qRT-PCR (and normalized to EF-1a
mRNA) in cell fractions obtained from umbilical cord blood (A) or
peripheral blood from adults (B). In erythrocytes, no UCP2 transcript
could be detected. Data are representative of two independent
experiments. MNC, mononuclear cells; RBC, red blood cells.
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ated cells containing hemoglobin. However, very few cells with
morphology suggesting the erythroid lineage were stained
positive, explaining why we did not detect UCP2 expression
in erythroid cells before in our mice [1] or in human [2] devel-
opmental studies. In contrast to some studies in adult rodents
reviewed previously [2], UCP2 gene expression could not bedetected in hepatocytes. This discrepancy may be related to
the status of the liver, where UCP2 expression in hepatocytes
may be induced by inﬂammation, steatosis, or neoplastic trans-
formation (see [2] for references).
Also, our results from hypoxia experiment are in agreement
with the expression of UCP2 gene in maturating RBC. In
peripheral blood of adult mice, hypoxia induced a biphasic rise
in the abundance of the transcripts for UCP2 and the reticulo-
cyte marker HBB-b1, as well as hematocrit with a peak at-
tained during the second week of exposure. In humans,
transient increase of hemoglobin and hematocrit at the begin-
ning of adaptation to high altitude hypoxia was associated
with a rapid decrease of plasma volume, and followed by an
increase in erythropoiesis, until the number of mature RBC
was stabilized at a higher level [17] with maximal reticulocyto-
sis after about 8–10 days [18].
That erythroid cells express UCP2 transcript was demon-
strated unequivocally in peripheral blood of humans. Com-
pared to granulocytes and MNC, the expression of UCP2 in
total RBC fractions and in reticulocytes was surprisingly high.
Based on the relatively high expression of UCP2 in RBC from
umbilical blood, it can be speculated that besides reticulocytes,
also other erythroid cells exert high expression of UCP2, pos-
sibly erythroblasts (normoblasts), which are abundant in blood
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relation between UCP2 transcript levels and diﬀerential blood
cell count data obtained in the human umbilical blood (not
shown). However, in order to quantify UCP2 protein in blood
cells in future studies, isolation of mitochondria from these
cells will be probably required before the Western blot analysis
(see e.g. [3]).
UCP2 expression was detected in reticulocytes but not in
erythrocytes, in agreement with the notion that mitochondria,
the organelles bearing UCP2, are expelled from reticulocytes
during their maturation into erythrocytes while glycolysis is
activated. Interestingly, also UCP3 is expressed in reticulocytes
[19]. Reticulocytes are formed by enucleation of late-stage ery-
throblasts. Reticulocytes can no longer synthesize mRNA, but
they can translate existing messages, they synthesize enormous
amount of hemoglobin, and they still have internal organelles.
Since erythroid cells are regularly exposed to ROS generated
by high concentration of iron (Fe-hemoglobin acting as a po-
tent catalyzer of ROS formation), a protection system is essen-
tial to complete their maturation. Therefore, it is tempting to
speculate that especially in reticulocytes, UCP2 has an impor-
tant role in the control of mitochondrial ROS production. The
functional importance of UCP2 for reticulocytes is supported
by the strong association between expression of UCP2 and
of the reticulocyte marker, HBB, in peripheral blood during
hypoxia exposure. Moreover, induction of erythropoiesis dur-
ing hypoxia is mediated by erythropoietin, which also induces
generation of ROS, and in turn, ROS modulate cell progres-
sion (see Section 1). Further research should clarify whether
UCP2 could be an active player in control of erythroid cells
diﬀerentiation and progression.
In summary our results document speciﬁc expression of
UCP2 in hematopoietic cells from the early stages of their pre-
natal development, and a surprisingly strong expression of this
gene in maturating erythroid cells, including reticulocytes. Our
results suggest involvement of UCP2 in erythropoiesis, starting
from early stages of the prenatal development.
Acknowledgments: This work was supported by the European Commis-
sion (FOOD-CT-2005-007036), the Research Project AVOZ50110509,
and the Wellcome Trust (070821/Z/03/Z). The authors thank to
Prof. Daniel Ricquier for the helpful discussion and for the hUCP2-
605 antibodies and Dr. Vidya Mohamed-Ali for the critical reading
of the manuscript.References
[1] Hodny, Z., Kolarova, P., Rossmeisl, M., Horakova, M., Nibbe-
link, M., Penicaud, L., Casteilla, L. and Kopecky, J. (1998) High
expression of uncoupling protein 2 in foetal liver. FEBS Lett. 425,
185–190.
[2] Brauner, P., Nibbelink, M., Flachs, P., Vitkova, I., Kopecky, P.,
Mertelikova, I., Janderova, L., Penicaud, L., Casteilla, L., Plavka,
R. and Kopecky, J. (2001) Fast decline of hematopoiesis and
uncoupling protein 2 content in human liver after birth: location
of the protein in Kupﬀer cells. Pediatr. Res. 49, 440–447.
[3] Alves-Guerra, M.C., Rousset, S., Pecqueur, C., Mallat, Z., Blanc,
J., Tedgui, A., Bouillaud, F., Cassard-Doulcier, A.M., Ricquier,
D. and Miroux, B. (2003) Bone marrow transplantation revealsthe in vivo expression of the mitochondrial uncoupling protein 2
in immune and nonimmune cells during inﬂammation. J. Biol.
Chem. 278, 42307–42312.
[4] Negre-Salvayre, Hirtz, C., Carrera, G., Cazenave, R., Troly, M.,
Salvayre, R., Penicaud, L. and Casteilla, L. (1997) A role for
uncoupling protein-2 as a regulator of mitochondrial hydrogen
peroxide generation. FASEB J. 11, 809–816.
[5] Brand, M.D. and Esteves, T.C. (2005) Physiological functions of
the mitochondrial uncoupling proteins UCP2 and UCP3. Cell
Metab. 2, 85–93.
[6] Nishio, K., Qiao, S. and Yamashita, H. (2005) Characterization
of the diﬀerential expression of uncoupling protein 2 and ROS
production in diﬀerentiated mouse macrophage-cells (Mm1) and
the progenitor cells (M1). J. Mol. Histol. 36, 35–44.
[7] Arsenijevic, D., Onuma, H., Pecqueur, C., Raimbault, S.,
Manning, B.S., Miroux, B., Couplan, E., Alves-Guerra, M.C.,
Goubern, M., Surwit, R., Bouillaud, F., Richard, D., Collins, S.
and Ricquier, D. (2000) Disruption of the uncoupling protein-2
gene in mice reveals a role in immunity and reactive oxygen
species production. Nat. Genet. 26, 435–439.
[8] Horimoto, M., Fulop, P., Derdak, Z., Wands, J.R. and Baﬀy, G.
(2004) Uncoupling protein-2 deﬁciency promotes oxidant stress
and delays liver regeneration in mice. Hepatology 39, 386–392.
[9] Blanc, J., Alves-Guerra, M.C., Esposito, B., Rousset, S., Gourdy,
P., Ricquier, D., Tedgui, A., Miroux, B. and Mallat, Z. (2003)
Protective role of uncoupling protein 2 in atherosclerosis.
Circulation 107, 388–390.
[10] Iiyama, M., Kakihana, K., Kurosu, T. and Miura, O. (2006)
Reactive oxygen species generated by hematopoietic cytokines
play roles in activation of receptor-mediated signaling and in cell
cycle progression. Cell Signal. 18, 174–182.
[11] Sattler, M., Winkler, T., Verma, S., Byrne, C.H., Shrikhande, G.,
Salgia, R. and Griﬃn, J.D. (1999) Hematopoietic growth factors
signal through the formation of reactive oxygen species. Blood 93,
2928–2935.
[12] Schimenti, K.J., Lacerna, K., Wamble, A., Maston, L., Iaﬀald-
ano, C., Straight, M., Rabinovitch, A., Lazarus, H.M. and
Jacobberger, J.W. (1992) Reticulocyte quantiﬁcation by ﬂow
cytometry, image analysis, and manual counting. Cytometry 13,
853–862.
[13] Brauner, P., Kopecky, P., Flachs, P., Ruﬀer, J., Sebron, V.,
Plavka, R., Vitkova, I., Vorlicek, J. and Kopecky, J. (2002)
Induction of uncoupling protein 3 gene expression in skeletal
muscle of preterm newborns. Pediat. Res. 53, 691–697.
[14] Flachs, P., Horakova, O., Brauner, P., Rossmeisl, M., Pecina, P.,
Franssen-van Hal, N.L., Ruzickova, J., Sponarova, J., Drahota,
Z., Vlcek, C., Keijer, J., Houstek, J. and Kopecky, J. (2005)
Polyunsaturated fatty acids of marine origin upregulate mito-
chondrial biogenesis and induce beta-oxidation in white fat.
Diabetologia 48, 2365–2375.
[15] Bonafoux, B., Lejeune, M., Piquemal, D., Quere, R., Baudet, A.,
Assaf, L., Marti, J., Aguilar-Martinez, P. and Commes, T. (2004)
Analysis of remnant reticulocyte mRNA reveals new genes and
antisense transcripts expressed in the human erythroid lineage.
Haematologica 89, 1434–1438.
[16] Fujiwara, T., Harigae, H., Takahashi, S., Furuyama, K., Nakaj-
ima, O., Sun, J., Igarashi, K., Yamamoto, M., Sassa, S., Kaku,
M. and Sasaki, T. (2006) Diﬀerential gene expression proﬁling
between wild-type and ALAS2-null erythroblasts: identiﬁcation of
novel heme-regulated genes. Biochem. Biophys. Res. Commun.
340, 105–110.
[17] Hogan, R.P., Kotchen, T.A., Boyd III, A.E. and Hartley, L.H.
(1973) Eﬀect of altitude on renin-aldosterone system and metab-
olism of water and electrolytes. J. Appl. Physiol. 35, 385–390.
[18] Berglund, B. (1992) High-altitude training. Aspects of haemato-
logical adaptation. Sports Med. 14, 289–303.
[19] Carroll, A.M. and Porter, R.K. (2004) Starvation-sensitive UCP 3
protein expression in thymus and spleen mitochondria. Biochim.
Biophys. Acta 1700, 145–150.
